Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-06

Clinical Trial Update: SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry

View source ↗

Summary

Clinical trial update for the SECURE Crohn's disease post-marketing registry has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Crohn's Disease | Status: COMPLETED | Results posted: 2023-05-06